Orphan Drug Status

Opinion

... in response to Genervon's GM604 bio-drug receives FDA orphan drug designation for ALS treatment

Orphan Drug Status

Neville Pearson says:

July 23, 2014 at 8:14 PM

In the case of Genervon's GM604, what does "fast track" and "orphan drug" status mean in the real world as far as a TIME FRAME goes? someone out there must be able to come up with a best guess as to how much longer the clinical trials will take and thus an anticipated date for availability to ALS sufferers. This is one thing that no-one ever mentions in all the hyped up press releases etc., I would just like to know if we are talking about months, years, or decades.

0 0

Reply
- Dieter Loemker on Genervon's GM604 bio-drug receives FDA orphan drug designation for ALS treatment
  
  Dieter Loemker says:
  
  June 21, 2015 at 5:53 PM
  
  Hi Neville, I know exactly what you are going thru I'm a sufferer also this fast track is a bit of a joke people with this condition need this drug now and as far as I'm concerned don't tell us about a new drug unless its available tomorrow
  
  0 0
  
  Reply

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.